Search for: "Genentech, Inc."
Results 41 - 60
of 469
Sort by Relevance
|
Sort by Date
7 Nov 2021, 9:50 pm
Patent & Trademark Office, and Derek Maetzold of Castle Biosciences, Inc. [read post]
6 Nov 2021, 9:19 pm
Patent & Trademark Office, and Derek Maetzold of Castle Biosciences, Inc. [read post]
26 Oct 2021, 6:53 am
Prometheus Labs., Inc., 132 S. [read post]
24 Sep 2021, 2:27 pm
Starting at the top, “the relative convenience for and cost of attendance of witnesses between the two forums is ‘probably the single most important factor in transfer analysis.'” Slip Op. at 7, quoting In re Genentech, Inc., 566 F.3d 1338, 1343 (Fed. [read post]
8 Sep 2021, 7:50 am
In undoubtedly one of the most important decisions of the year so far, on 24 August 2021, the English Court of Appeal handed down its judgment in FibroGen v Akebia (FibroGen Inc v Akebia Therapeutics Inc [2021] EWCA Civ 1279), partially allowing FibroGen’s appeal, and so finding one of the ‘Family A’ patents, EP 823, valid and infringed. [read post]
2 Aug 2021, 8:06 am
” In re Genentech, Inc., 566 F.3d 1338 (Fed. [read post]
7 Jun 2021, 6:36 am
Genentech, Inc., 549 U.S. 118 (2007). [read post]
24 May 2021, 7:34 am
The plaintiffs have accused Ranbaxy of delaying the launch of generic versions of Novartis AG’s high blood pressure drug Diovan, Pfizer Inc’s acid reflux drug Nexium and Genentech Inc’s antiviral drug Valcyte. [read post]
19 May 2021, 10:40 am
Genentech, Inc., 549 U.S. 118 (2007); Cardinal Chem. [read post]
12 May 2021, 4:00 am
” – Genentech, Inc. v. [read post]
7 Apr 2021, 9:30 am
Genentech, Inc., 529 U.S. 118 (2007), the Supreme Court held that a patent licensee has standing to challenge a patent’s validity even without stopping the royalty payments. [read post]
13 Feb 2021, 9:11 pm
Jill Schmidt of Genentech, Inc.; Susan Tull of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Sharonmoyee Goswami of Cravath, Swaine & Moore LLP; and Andrew R. [read post]
19 Dec 2020, 9:15 am
Genentech, Inc. [read post]
7 Sep 2020, 6:44 pm
Genentech, Inc., 2020 WL 5048435 (Fed. [read post]
1 Sep 2020, 9:40 am
Genentech, Inc. [read post]
1 Sep 2020, 9:40 am
Genentech, Inc. [read post]
30 Aug 2020, 9:40 pm
Genentech, Inc. [read post]
27 Jul 2020, 2:04 am
., AbCellera Biologics, Amgen Inc., AstraZeneca, Genentech and GlaxoSmithKline to share information about producing the antibody treatments needed to treat COVID-19. [read post]
10 Jul 2020, 2:12 pm
Amgen Inc., 137 S. [read post]
7 Jul 2020, 8:22 pm
Noonan -- In a procedurally unusual decision (but one unsurprising in all other respects), the Federal Circuit on Monday affirmed a district court's denial of a temporary restraining order to keep off the market Amgen's biosimilar product Mvasi in Genentech, Inc. v. [read post]
